Dengshuai E. Wei

Qingdao, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Self-Assembly of Peptide-Lipid Platinum(IV) Prodrug Amphiphile for αvβ3 Integrin-Targeting Chemotherapy.

Self-Assembly of Peptide-Lipid Platinum(IV) Prodrug Amphiphile for αvβ3 Integrin-Targeting Chemotherapy.

Journal: Advanced healthcare materials
Published: March 08, 2026

Corrigendum to "Nucleic acid-based nanogels with 'offensive and defensive' effects for enhanced chemo-immunotherapy" [Journal of Controlled Release 385 (2025) 113977].

Corrigendum to "Nucleic acid-based nanogels with 'offensive and defensive' effects for enhanced chemo-immunotherapy" [Journal of Controlled Release 385 (2025) 113977].

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: July 13, 2025

Nucleic acid-based nanogels with "offensive and defensive"effects for enhanced chemo-immunotherapy.

Nucleic acid-based nanogels with "offensive and defensive"effects for enhanced chemo-immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 09, 2025

A biotin guided PtIV amphiphilic prodrug synergized with CDK4/6 inhibition for enhanced tumor targeted therapy.

A biotin guided PtIV amphiphilic prodrug synergized with CDK4/6 inhibition for enhanced tumor targeted therapy.

Journal: Nanoscale
Published: March 26, 2025

Biotin Receptor-Targeting PtIV Oxygen Carrying Prodrug Amphiphile for Alleviating Tumor Hypoxia Induced Immune Chemotherapy Suppression.

Biotin Receptor-Targeting PtIV Oxygen Carrying Prodrug Amphiphile for Alleviating Tumor Hypoxia Induced Immune Chemotherapy Suppression.

Journal: ACS nano
Published: March 04, 2025

Nucleic acid-based delivery system delivering platinum drugs cooperates with siRNA for potentiated chemo-immunotherapy by reducing phosphatidylserine exposure and activating the cGAS-STING pathway.

Nucleic acid-based delivery system delivering platinum drugs cooperates with siRNA for potentiated chemo-immunotherapy by reducing phosphatidylserine exposure and activating the cGAS-STING pathway.

Journal: Acta pharmaceutica Sinica. B
Published: January 08, 2025

Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca2+ trapping.

Osteosarcoma-targeting PtIV prodrug amphiphile for enhanced chemo-immunotherapy via Ca2+ trapping.

Journal: Acta biomaterialia
Published: October 11, 2024

Construction of a Multifunctional Upconversion Nanoplatform Based on Autophagy Inhibition and Photodynamic Therapy Combined with Chemotherapy for Antitumor Therapy.

Construction of a Multifunctional Upconversion Nanoplatform Based on Autophagy Inhibition and Photodynamic Therapy Combined with Chemotherapy for Antitumor Therapy.

Journal: Molecular pharmaceutics
Published: August 06, 2024

Nucleus-targeting Oxaplatin(IV) prodrug Amphiphile for enhanced chemotherapy and immunotherapy.

Nucleus-targeting Oxaplatin(IV) prodrug Amphiphile for enhanced chemotherapy and immunotherapy.

Journal: Journal of controlled release : official journal of the Controlled Release Society
Published: April 13, 2024

Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics.

Stimuli-Responsive Polymer-Based Nanosystems for Cancer Theranostics.

Journal: ACS nano
Published: December 02, 2023

Anatase TiO2-x and zwitterionic porphyrin polymer-based nanocomposite for enhanced cancer photodynamic therapy.

Anatase TiO2-x and zwitterionic porphyrin polymer-based nanocomposite for enhanced cancer photodynamic therapy.

Journal: Nanoscale
Published: August 29, 2023

Alendronate PtIV Prodrug Amphiphile for Enhanced Chemotherapy Targeting and Bone Destruction Inhibition in Osteosarcoma.

Alendronate PtIV Prodrug Amphiphile for Enhanced Chemotherapy Targeting and Bone Destruction Inhibition in Osteosarcoma.

Journal: Advanced healthcare materials
Published: August 20, 2023
Showing 1-12 of 15

Last Updated: 09/26/2026